ImpriMed Unveils Cancer Treatment Prediction Technology at EHA-SfPM Meeting, Expands AI-Driven Precision Medicine Services ...

With FDA approval for imetelstat and solid financials, Geron shows great promise in MDS treatment. Read more on GERN stock ...

Annamycin is currently being evaluated in continuing clinical trials for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. Annamycin has Fast ...

TC Biopharm (NASDAQ: TCBP) , a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, has announced a key step in its ...

The Philippine Society for Blood and Bone Marrow Transplantation is holding its eighth post-graduate course this weekend with the theme: Transplant 360°: Stakeholders’ Perspectives on HSCT at the ...

I was diagnosed with Chronic Myeloid Leukemia, a blood cancer that now in 2024 has excellent survival rates if your body can ...

AbbVie ABBV announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended approving the ...

Sutro Biopharma specializes in ADCs for oncology and shows promise with STRO-002 for ovarian cancer and collaborations with ...

ONCO Prime is a cutting-edge drug discovery platform identifying novel synthetic lethal targets using patient-derived primary cell cultures. Initial data have identified potentially novel drug targets ...